Viewing Study NCT02468102


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-02-25 @ 5:33 PM
Study NCT ID: NCT02468102
Status: COMPLETED
Last Update Posted: 2021-09-27
First Post: 2015-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module